NASDAQ | ETF
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 5.57% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.44% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.32% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.39% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.15% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.75% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.50% |
INSM | Insmed Inc | Healthcare | Biotechnology | 1.34% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.30% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.30% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.20% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.17% |
RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.14% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.03% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.01% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 1.00% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.97% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 0.96% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 0.92% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 0.90% |